The Fap2 protein of Fn can interact with T-cell immune receptor with Ig and ITIM domain on tumor-infiltrating lymphocytes, inhibiting Natural Killer (NK) cell toxicity and T cell-mediated anti-CRC immune response, potentially affecting the efficacy of CRC immunotherapy (Gur et al., 2015). The gene discussed is FN1; the disease is neoplasm.